ConductScience.org, home

Paper13620740

Medullary (solid) carcinoma of the thyroid; a clinicopathologic entity.

HAZARD JB and 2 others. J Clin Endocrinol Metab, 1959. Cited by 724 papers, by iCite.

Cite this record

ConductScience Library. Medullary (solid) carcinoma of the thyroid; a clinicopathologic entity. Papers, record 13620740. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/13620740

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Medullary (solid) carcinoma of the thyroid; a clinicopathologic entity.
PubMed
Journal
J Clin Endocrinol Metab
PubMed
Year
1959
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
724
iCite
Revised in PubMed
2022-04-08
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1HAZARD JBJ B
2HAWK WAW A
3CRILE G JrG

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adrenal MedullaMajor topic
CarcinomaMajor topic
NeoplasmsMajor topic
Thyroid GlandMajor topic
Thyroid NeoplasmsMajor topic
Humans

Cited by147

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 724 citations.

PMIDTitleJournalYearIn PapersSource
41374422Amyloid A Amyloidosis Secondary to Thymoma.Diagnostics (Basel)2025https://conductscience.org/library/papers/41374422PubMed
40853492Clinical prognostic risk assessment of different pathological subtypes of papillary thyroid cancer: a systematic review and network meta-analysis.Langenbecks Arch Surg2025https://conductscience.org/library/papers/40853492PubMed
40715712Geospatial inheritance across the breath of the RET mutational landscape of multiple endocrine neoplasia 2A.Endocrine2025https://conductscience.org/library/papers/40715712PubMed
40464083Combining Procalcitonin and Calcitonin for the Diagnosis of Medullary Thyroid Cancer: A Two-Step Approach.Clin Endocrinol (Oxf)2025https://conductscience.org/library/papers/40464083PubMed
40340909MEN2: surgical precision in the era of precision medicine.Endocr Relat Cancer2025https://conductscience.org/library/papers/40340909PubMed
40102261Surgical Treatment of Medullary Thyroid Cancer.Recent Results Cancer Res2025https://conductscience.org/library/papers/40102261PubMed
40102255Epidemiology, Clinical Presentation, and Diagnosis of Medullary Thyroid Carcinoma.Recent Results Cancer Res2025https://conductscience.org/library/papers/40102255PubMed
40102254Thyroid C-Cell Biology and Oncogenic Transformation.Recent Results Cancer Res2025https://conductscience.org/library/papers/40102254PubMed
40102253Histopathology of C Cells and Medullary Thyroid Carcinoma.Recent Results Cancer Res2025https://conductscience.org/library/papers/40102253PubMed
40075585Validation of the International Medullary Thyroid Cancer Grading System and Identification of EZH2 as a Prognostic and Potential Therapeutic Marker in Medullary Thyroid Cancer.Cancers (Basel)2025https://conductscience.org/library/papers/40075585PubMed
39009923Treatment and management of medullary thyroid microcarcinoma: a 10-year retrospective study from a single center.Endocrine2024https://conductscience.org/library/papers/39009923PubMed
38806713[30 years of prophylactic thyroidectomy for hereditary medullary thyroid cancer : A milestone in translational medicine].Chirurgie (Heidelb)2024https://conductscience.org/library/papers/38806713PubMed
38745826Medullary Thyroid Cancer: Epidemiology and Characteristics According to Data From the Marne-Ardennes Register 1975-2018.J Endocr Soc2024https://conductscience.org/library/papers/38745826PubMed
38010402International medullary thyroid carcinoma grading system: an Indian tertiary care centre experience.Eur Arch Otorhinolaryngol2024https://conductscience.org/library/papers/38010402PubMed
37835559Molecular Basis and Natural History of Medullary Thyroid Cancer: It is (Almost) All in the RET.Cancers (Basel)2023https://conductscience.org/library/papers/37835559PubMed
37715050Molecular imaging and related therapeutic options for medullary thyroid carcinoma: state of the art and future opportunities.Rev Endocr Metab Disord2024https://conductscience.org/library/papers/37715050PubMed
37511745Personalized Medicine in Medullary Thyroid Carcinoma: A Broad Review of Emerging Treatments.J Pers Med2023https://conductscience.org/library/papers/37511745PubMed
37270155Independent Validation of the International Grading System for Medullary Thyroid Carcinoma: A Single Institution Experience.Mod Pathol2023https://conductscience.org/library/papers/37270155PubMed
36672624Clinicopathological Profile of Medullary Thyroid Carcinoma-Could We Predict Aggressive Behavior?Biomedicines2023https://conductscience.org/library/papers/36672624PubMed
36600874Case Report: A Challenging Clinical Problem of Calcitonin-Negative Medullary Thyroid Cancer Diagnosis and Surveillance.Cureus2022https://conductscience.org/library/papers/36600874PubMed

See all 147 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/13620740

GET https://conductscience.org/api/papers/v1/13620740/cited_by?page=2